Zejula Euroopa Liit - eesti - EMA (European Medicines Agency)

zejula

glaxosmithkline (ireland) limited - niraparib (tosilate monohydrate) - fallopian tube neoplasms; peritoneal neoplasms; ovarian neoplasms - antineoplastilised ained - zejula is indicated: , as monotherapy for the maintenance treatment of adult patients with advanced epithelial (figo stages iii and iv) high-grade ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. , as monotherapy for the maintenance treatment of adult patients with platinum sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum based chemotherapy.

ZEJULA kõvakapsel Eesti - eesti - Ravimiamet

zejula kõvakapsel

tesaro bio netherlands b.v. - nirapariib - kõvakapsel - 100mg 56tk

ZEJULA õhukese polümeerikattega tablett Eesti - eesti - Ravimiamet

zejula õhukese polümeerikattega tablett

millmount healthcare limited - nirapariib - õhukese polümeerikattega tablett - 100mg 56tk